Co-Diagnostics Shares Drop After New Resale Filing
Co-Diagnostics shares dropped hard on the Nasdaq in early trading Monday. It was the first regular session after the U.S. Securities and Exchange Commission made effective a resale registration statement linked to a recent private placement. The share price was at $6.71, down $1.83 from the $8.53 close on Friday. The stock swung between $5.11 and $10.18 during the session. The move pointed to high volatility in the small-cap diagnostics stock.